000 01337 a2200337 4500
005 20250513211204.0
264 0 _c20000530
008 200005s 0 0 eng d
022 _a0003-9926
024 7 _a10.1001/archinte.160.9.1277
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElliott, W J
245 0 0 _aCost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
_h[electronic resource]
260 _bArchives of internal medicine
_cMay 2000
300 _a1277-83 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntihypertensive Agents
_xeconomics
650 0 4 _aComputer Simulation
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aDrug Therapy
_xeconomics
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMiddle Aged
700 1 _aWeir, D R
700 1 _aBlack, H R
773 0 _tArchives of internal medicine
_gvol. 160
_gno. 9
_gp. 1277-83
856 4 0 _uhttps://doi.org/10.1001/archinte.160.9.1277
_zAvailable from publisher's website
999 _c10760894
_d10760894